Toggle navigation
About Us
Science & Innovation
Products and Resources
Our Responsibility
Careers
Investors
Media
Toggle navigation
Press Releases
Featured News
Press Statements
Subscribe
Media Contacts
Press Releases
Month Year
Su
Mo
Tu
We
Th
Fr
Sa
25
26
27
28
29
30
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
1
2
3
4
5
Cancel
OK
Month Year
Su
Mo
Tu
We
Th
Fr
Sa
25
26
27
28
29
30
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
1
2
3
4
5
Cancel
OK
Year
All Years
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
Category
All Categories
Corporate News
Product News
Vaccines News
Uncategorized
Keywords
Go
Advanced Search
Search
Search Headlines Only
Category
All Categories
Corporate News
Product News
Vaccines News
Uncategorized
From
To
Asset Types
Video
Audio
Photos
Documents
Events
Standard
Feb 2, 2005
Sanofi-aventis receives FDA approval for new Eloxatin™ formulation
Jan 26, 2005
2004 pro forma combined net sales: up 10.0% on a comparable basis
Jan 25, 2005
Plavix® patent
Jan 25, 2005
Sanofi-aventis “Solidarity Day” offers additional aid, assistance to Southeast Asia “Sharing in solidarity”
Jan 19, 2005
The European Commission imposes a fine on certain MCAA producers
Show
5
10
25
50
100
per page
«
1
…
177
178
179
180
181
182
183
184
185
»
Print
Email page
RSS